| 摘要: |
| 钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂是治疗2型糖尿病的新型药物,简介钠-葡萄糖协同转运蛋白2抑制剂的研究现状,重点分析钠-葡萄糖协同转运蛋白2抑制剂的专利申请量、申请人、重点专利等,梳理出钠-葡萄糖协同转运蛋白2抑制剂的技术发展过程。 |
| 关键词: 钠-葡萄糖协同转运蛋白2抑制剂 糖尿病 专利分析 |
| DOI:10.13506/j.cnki.jpr.2019.05.014 |
| 基金项目: |
|
|
|
| Analysis of patent technology of antidiabetics——SGLT-2 inhibitors |
| HOU Qin,ZHOU Qiong,ZHAO Chunlin,ZHANG Jingsai |
| (Patent Examination Cooperation Center of the Patent Office,CNIPA,Tianjin 300304,China) |
| Abstract: |
| SGLT-2 inhibitors are novel medicines for treating type 2 diabetes.The research status of SGLT-2 inhibitors were reviewed in this paper.The number of SGLT-2 inhibitor related patent applications,as well as the applicants,and important applications were analyzed.The technology development process of SGLT-2 inhibitors were introduced. |
| Key words: SGLT-2 inhibitor Diabetes Patent analysis |